Form 8-K - Current report:
SEC Accession No. 0001193125-25-004124
Filing Date
2025-01-10
Accepted
2025-01-10 08:06:43
Documents
40
Period of Report
2025-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d909966d8k.htm   iXBRL 8-K 42554
2 EX-99.1 d909966dex991.htm EX-99.1 23813
3 EX-99.2 d909966dex992.htm EX-99.2 28826
7 GRAPHIC g909966ex99_2p10g1.jpg GRAPHIC 215116
8 GRAPHIC g909966ex99_2p11g1.jpg GRAPHIC 309804
9 GRAPHIC g909966ex99_2p12g1.jpg GRAPHIC 223291
10 GRAPHIC g909966ex99_2p13g1.jpg GRAPHIC 229187
11 GRAPHIC g909966ex99_2p14g1.jpg GRAPHIC 265128
12 GRAPHIC g909966ex99_2p15g1.jpg GRAPHIC 326191
13 GRAPHIC g909966ex99_2p16g1.jpg GRAPHIC 300210
14 GRAPHIC g909966ex99_2p17g1.jpg GRAPHIC 232617
15 GRAPHIC g909966ex99_2p18g1.jpg GRAPHIC 312359
16 GRAPHIC g909966ex99_2p19g1.jpg GRAPHIC 219693
17 GRAPHIC g909966ex99_2p1g1.jpg GRAPHIC 316809
18 GRAPHIC g909966ex99_2p20g1.jpg GRAPHIC 372968
19 GRAPHIC g909966ex99_2p21g1.jpg GRAPHIC 270067
20 GRAPHIC g909966ex99_2p22g1.jpg GRAPHIC 375675
21 GRAPHIC g909966ex99_2p23g1.jpg GRAPHIC 110770
22 GRAPHIC g909966ex99_2p24g1.jpg GRAPHIC 380158
23 GRAPHIC g909966ex99_2p25g1.jpg GRAPHIC 63834
24 GRAPHIC g909966ex99_2p2g1.jpg GRAPHIC 579508
25 GRAPHIC g909966ex99_2p3g1.jpg GRAPHIC 394365
26 GRAPHIC g909966ex99_2p4g1.jpg GRAPHIC 341141
27 GRAPHIC g909966ex99_2p5g1.jpg GRAPHIC 297171
28 GRAPHIC g909966ex99_2p6g1.jpg GRAPHIC 342630
29 GRAPHIC g909966ex99_2p7g1.jpg GRAPHIC 316000
30 GRAPHIC g909966ex99_2p8g1.jpg GRAPHIC 356932
31 GRAPHIC g909966ex99_2p9g1.jpg GRAPHIC 177514
  Complete submission text file 0001193125-25-004124.txt   10342596

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA inzy-20250110.xsd EX-101.SCH 2851
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE inzy-20250110_lab.xml EX-101.LAB 18738
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inzy-20250110_pre.xml EX-101.PRE 11708
42 EXTRACTED XBRL INSTANCE DOCUMENT d909966d8k_htm.xml XML 3762
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

EIN.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39397 | Film No.: 25520527
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)